









Markets
/
Stocks
/
nasdaq-stvn
/

Stevanato Group SpA

STVN

15.500USD

+1.350+9.54%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

4.23BMarket Cap

35.26P/E TTM



Stevanato Group SpA

15.500

+1.350+9.54%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Stevanato Group SpA

Currency: USD Updated: 2026-02-06

Key Insights

Stevanato Group SpA's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 58 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.99.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stevanato Group SpA's Score

Industry at a Glance

Industry Ranking

58 / 205

Overall Ranking

162 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Stevanato Group SpA Highlights

StrengthsRisks

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.

Undervalued

The company’s latest PE is 35.26, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 53.34M shares, decreasing 22.52% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 945.00 shares of this stock.

Analyst Rating

Based on 11 analysts

Buy

Current Rating

28.993

Target Price

+104.90%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Stevanato Group SpA is 8.47, ranking 43 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 262.55M, representing a year-over-year increase of 3.28%, while its net profit experienced a year-over-year increase of 13.69%.

Score

Industry at a Glance

Previous score

8.47

Change



Financials

6.85

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.56

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.40

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.56

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Stevanato Group SpA's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Stevanato Group SpA is 4.10, ranking 196 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 35.26, which is 97.59% below the recent high of 69.67 and 8.71% above the recent low of 32.19.

Score

Industry at a Glance

Previous score

4.10

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 58/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Stevanato Group SpA is 8.36, ranking 42 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 37.00 and a low of 23.00.

Score

Industry at a Glance

Previous score

8.36

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 11 analysts

Buy

Current Rating

28.993

Target Price

+104.90%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Stevanato Group SpA

STVN

Stryker Corp

SYK

Medtronic PLC

MDT

Dexcom Inc

DXCM

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Stevanato Group SpA is 6.85, ranking 79 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 20.36 and the support level at 12.27, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.55

Change

0.3

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.456

Sell

RSI(14)

33.178

Neutral

STOCH(KDJ)(9,3,3)

23.103

Buy

ATR(14)

1.227

High Vlolatility

CCI(14)

-69.335

Neutral

Williams %R

73.632

Sell

TRIX(12,20)

-1.276

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

15.082

Buy

MA10

15.726

Sell

MA20

17.781

Sell

MA50

19.995

Sell

MA100

22.404

Sell

MA200

23.081

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Stevanato Group SpA is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 107.30%, representing a quarter-over-quarter decrease of 4.42%. The largest institutional shareholder is Ron Baron, holding a total of 1.97M shares, representing 3.97% of shares outstanding, with 6.55% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Conestoga Capital Advisors, LLC

8.09M

-0.37%

Neuberger Berman, LLC

4.96M

+1.78%

T. Rowe Price Investment Management, Inc.

3.55M

-4.83%

TimesSquare Capital Management, LLC

3.27M

-1.74%

Thrivent Asset Management, LLC

2.37M

+7.07%

Artisan Partners Limited Partnership

2.61M

-4.41%

Baron Capital Management, Inc.

Star Investors

1.97M

+4.54%

Jennison Associates LLC

1.56M

+43.65%

ArrowMark Colorado Holdings, LLC

1.39M

+6.66%

Pembroke Management Ltd.

1.28M

+11.92%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Stevanato Group SpA is 5.24, ranking 86 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.59. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.